141 related articles for article (PubMed ID: 18310536)
21. Improvement of mouse beta-thalassemia upon erythropoietin delivery by encapsulated myoblasts.
Dalle B; Payen E; Regulier E; Deglon N; Rouyer-Fessard P; Beuzard Y; Aebischer P
Gene Ther; 1999 Feb; 6(2):157-61. PubMed ID: 10435099
[TBL] [Abstract][Full Text] [Related]
22. On the road to gene therapy for beta-thalassemia and sickle cell anemia.
Bank A
Pediatr Hematol Oncol; 2008; 25(1):1-4. PubMed ID: 18231949
[TBL] [Abstract][Full Text] [Related]
23. Gene therapy. Beta-thalassemia treatment succeeds, with a caveat.
Kaiser J
Science; 2009 Dec; 326(5959):1468-9. PubMed ID: 20007873
[No Abstract] [Full Text] [Related]
24. Update on gene therapy for hemoglobin disorders.
Persons DA
Curr Opin Mol Ther; 2003 Oct; 5(5):508-16. PubMed ID: 14601520
[TBL] [Abstract][Full Text] [Related]
25. A humanized BAC transgenic/knockout mouse model for HbE/beta-thalassemia.
Jamsai D; Zaibak F; Vadolas J; Voullaire L; Fowler KJ; Gazeas S; Peters H; Fucharoen S; Williamson R; Ioannou PA
Genomics; 2006 Sep; 88(3):309-15. PubMed ID: 16631345
[TBL] [Abstract][Full Text] [Related]
26. RISC control for gene therapy.
Qasim W; Thrasher AJ
Nat Biotechnol; 2006 Jun; 24(6):661-2. PubMed ID: 16763596
[No Abstract] [Full Text] [Related]
27. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
28. Towards gene therapy of hemoglobinopathies.
Beuzard Y
Semin Hematol; 1996 Jan; 33(1):43-52. PubMed ID: 8714584
[No Abstract] [Full Text] [Related]
29. Gene therapy on the Sly.
Sly WS
Nat Genet; 1993 Jun; 4(2):105-6. PubMed ID: 8348142
[No Abstract] [Full Text] [Related]
30. Gene therapy for hemoglobinopathies: are we there yet?
Puthenveetil G; Malik P
Curr Hematol Rep; 2004 Jul; 3(4):298-305. PubMed ID: 15217560
[TBL] [Abstract][Full Text] [Related]
31. NOD/SCID repopulating cells contribute only to short-term repopulation in the baboon.
Mezquita P; Beard BC; Kiem HP
Gene Ther; 2008 Nov; 15(21):1460-2. PubMed ID: 18563183
[TBL] [Abstract][Full Text] [Related]
32. A novel single step double positive double negative selection strategy for beta-globin gene replacement.
Khanahmad H; Noori Daloii MR; Shokrgozar MA; Azadmanesh K; Niavarani AR; Karimi M; Rabbani B; Khalili M; Bagheri R; Maryami F; Zeinali S
Biochem Biophys Res Commun; 2006 Jun; 345(1):14-20. PubMed ID: 16674923
[TBL] [Abstract][Full Text] [Related]
33. Transgenic mouse model for human genetic diseases.
Yamamura K; Tashiro F; Yi S; Wakasugi S; Araki S; Maeda S; Shimada K
Mol Reprod Dev; 1993 Oct; 36(2):248-50. PubMed ID: 8257578
[No Abstract] [Full Text] [Related]
34. Lentiviral vectors for gene therapy of heart disease.
Higuchi K; Medin JA
J Cardiol; 2007 Jan; 49(1):1-11. PubMed ID: 17269208
[TBL] [Abstract][Full Text] [Related]
35. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells.
Chen L; Chen D; Gong M; Na M; Li L; Wu H; Jiang L; Qian Y; Fang G; Xue X
Cancer Lett; 2009 Nov; 284(2):141-8. PubMed ID: 19447545
[TBL] [Abstract][Full Text] [Related]
36. Parthenogenetic embryonic stem cells derived from cryopreserved newborn mouse ovaries: a new approach to autologous stem cell therapy.
Xing F; Fang Z; Qin B; Li Y; Hou J; Chen X
Fertil Steril; 2009 Apr; 91(4):1238-44. PubMed ID: 18353322
[TBL] [Abstract][Full Text] [Related]
37. Amelioration of beta654-thalassemia in mouse model with the knockdown of aberrantly spliced beta-globin mRNA.
Xie S; Li W; Ren Z; Zhang J; Guo X; Wang S; Huang S; Zeng F; Zeng YT
J Genet Genomics; 2008 Oct; 35(10):595-601. PubMed ID: 18937916
[TBL] [Abstract][Full Text] [Related]
38. Globin gene transfer for the treatment of severe hemoglobinopathies: a paradigm for stem cell-based gene therapy.
Sadelain M
J Gene Med; 2002; 4(2):113-21. PubMed ID: 11933212
[TBL] [Abstract][Full Text] [Related]
39. Targeted gene modification in mouse ES cells using integrase-defective lentiviral vectors.
Okada Y; Ueshin Y; Hasuwa H; Takumi K; Okabe M; Ikawa M
Genesis; 2009 Apr; 47(4):217-23. PubMed ID: 19208434
[TBL] [Abstract][Full Text] [Related]
40. Production of lentiviruses displaying ''early-acting'' cytokines for selective gene transfer into hematopoietic stem cells.
Verhoeyen E; Nègre D; Cosset FL
Methods Mol Biol; 2008; 434():99-112. PubMed ID: 18470641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
